These Terms, our Privacy Policy, and any service-specific consent or notice should be read together
[3] For weight management: If discontinuing tirzepatide prescribed for obesity, consider: Establishing a structured nutrition and exercise program before stopping Transitioning to alternative weight management medications if appropriate Setting realistic expectations about weight regain Implementing behavioral strategies and support systems Regular weight monitoring and early intervention if significant regain occurs Practical discontinuation steps: If cost or access issues are driving discontinuation, discuss these openly with your healthcare team, as patient assistance programs, alternative formulations, or therapeutic substitutes may be available
Inject outside that area, not right next to the belly button
Insurers have plenty to consider when weighing coverage for new weight loss medications, and that includes the need to carefully coordinate distribution with their pharmacy benefit managers, according to a new playbook
Likewise, the estimated risk of nausea and vomiting can range between 5% to 78% risk for experiencing these side effects